nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.217	0.25	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.217	0.25	CbGbCtD
Ondansetron—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.163	0.187	CbGbCtD
Ondansetron—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.109	0.126	CbGbCtD
Ondansetron—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0999	0.115	CbGbCtD
Ondansetron—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0635	0.073	CbGbCtD
Ondansetron—Wound—Cyclosporine—focal segmental glomerulosclerosis	0.0182	0.191	CcSEcCtD
Ondansetron—SLC47A2—kidney—focal segmental glomerulosclerosis	0.00652	0.189	CbGeAlD
Ondansetron—SLC47A2—cortex of kidney—focal segmental glomerulosclerosis	0.00635	0.184	CbGeAlD
Ondansetron—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0514	CcSEcCtD
Ondansetron—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.0353	CcSEcCtD
Ondansetron—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00318	0.092	CbGeAlD
Ondansetron—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.0325	CcSEcCtD
Ondansetron—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.0316	CcSEcCtD
Ondansetron—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00272	0.0787	CbGeAlD
Ondansetron—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.0277	CcSEcCtD
Ondansetron—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.0277	CcSEcCtD
Ondansetron—SLC47A1—nephron tubule—focal segmental glomerulosclerosis	0.0026	0.0752	CbGeAlD
Ondansetron—SLC47A1—kidney—focal segmental glomerulosclerosis	0.00228	0.0661	CbGeAlD
Ondansetron—SLC47A1—cortex of kidney—focal segmental glomerulosclerosis	0.00222	0.0643	CbGeAlD
Ondansetron—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.0224	CcSEcCtD
Ondansetron—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.0212	CcSEcCtD
Ondansetron—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0208	CcSEcCtD
Ondansetron—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0171	CcSEcCtD
Ondansetron—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0163	CcSEcCtD
Ondansetron—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0153	CcSEcCtD
Ondansetron—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0152	CcSEcCtD
Ondansetron—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0151	CcSEcCtD
Ondansetron—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0147	CcSEcCtD
Ondansetron—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.014	CcSEcCtD
Ondansetron—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0139	CcSEcCtD
Ondansetron—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00132	0.0381	CbGeAlD
Ondansetron—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0134	CcSEcCtD
Ondansetron—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0129	CcSEcCtD
Ondansetron—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.00123	0.0355	CbGeAlD
Ondansetron—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0126	CcSEcCtD
Ondansetron—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0125	CcSEcCtD
Ondansetron—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0125	CcSEcCtD
Ondansetron—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0124	CcSEcCtD
Ondansetron—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00116	0.0335	CbGeAlD
Ondansetron—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0119	CcSEcCtD
Ondansetron—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00113	0.0326	CbGeAlD
Ondansetron—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0114	CcSEcCtD
Ondansetron—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0114	CcSEcCtD
Ondansetron—CYP2E1—kidney—focal segmental glomerulosclerosis	0.00108	0.0312	CbGeAlD
Ondansetron—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0112	CcSEcCtD
Ondansetron—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0111	CcSEcCtD
Ondansetron—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0111	CcSEcCtD
Ondansetron—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.00105	0.0304	CbGeAlD
Ondansetron—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0109	CcSEcCtD
Ondansetron—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0106	CcSEcCtD
Ondansetron—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.0105	CcSEcCtD
Ondansetron—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000982	0.0103	CcSEcCtD
Ondansetron—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000979	0.0103	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000975	0.0102	CcSEcCtD
Ondansetron—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00097	0.0102	CcSEcCtD
Ondansetron—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.0101	CcSEcCtD
Ondansetron—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000941	0.00989	CcSEcCtD
Ondansetron—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.0097	CcSEcCtD
Ondansetron—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.00961	CcSEcCtD
Ondansetron—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000868	0.0251	CbGeAlD
Ondansetron—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000854	0.0247	CbGeAlD
Ondansetron—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000845	0.00888	CcSEcCtD
Ondansetron—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000839	0.00882	CcSEcCtD
Ondansetron—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.00879	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000813	0.00854	CcSEcCtD
Ondansetron—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000812	0.00853	CcSEcCtD
Ondansetron—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.00846	CcSEcCtD
Ondansetron—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.00846	CcSEcCtD
Ondansetron—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000776	0.00815	CcSEcCtD
Ondansetron—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.00809	CcSEcCtD
Ondansetron—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000748	0.00786	CcSEcCtD
Ondansetron—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00782	CcSEcCtD
Ondansetron—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00782	CcSEcCtD
Ondansetron—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.00729	CcSEcCtD
Ondansetron—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000675	0.0071	CcSEcCtD
Ondansetron—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000666	0.007	CcSEcCtD
Ondansetron—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.00677	CcSEcCtD
Ondansetron—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000623	0.00654	CcSEcCtD
Ondansetron—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00629	CcSEcCtD
Ondansetron—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00624	CcSEcCtD
Ondansetron—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.00623	CcSEcCtD
Ondansetron—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00059	0.0062	CcSEcCtD
